NewsRoom Articles - Page 28 of 41

WednesdayNov 02, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Maintains Late 2022/Early 2023 for Full IND Application for DehydraTECH-CBD

Lexaria, through its patented DehydraTECH(TM) technology, is improving the bioavailability of pharmaceuticals and therapeutics (in part) by bypassing first-pass-liver processing, thereby achieving an improved speed of onset, and brain absorption of APIsHypertension currently affects nearly 50% of all American adults, with the American Heart Association describing it as a “silent killer”, and is now being studied for its effects during pregnancyThe company has received positive feedback for its pre-Investigational New Drug meeting from the FDA and has reported that it remains on track to file its full IND application by late 2022/early 2023 It looks to capitalize on the growth of…

TuesdayNov 01, 2022 11:15 am

Mullen Automotive Inc. (NASDAQ: MULN) ‘Strikingly Different’ Test Drive Tour Shines Spotlight on Mullen FIVE

Mullen’s U.S. test drive tour added additional dates, locations based on overwhelming responseTour provides hands-on opportunity to see the Mullen FIVESecond leg of tour, which will feature the Mullen FIVE RS, already in the planning stage Mullen Automotive (NASDAQ: MULN) is ending the year with a bang with its Mullen FIVE “Strikingly Different” U.S. Test Drive Tour (https://ibn.fm/eDWyL). The tour, which features the company’s innovative Mullen FIVE, kicked off in October. With additional locations added based on demand, the tour now has eight stops scheduled throughout November and December. “When we announced the [first] location, we received an overwhelmingly positive…

TuesdayNov 01, 2022 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Focusing on Execution and Brand Integration Following Successful Period of Strategic Investment

Flora Growth recently participated in an earnings call in which the management team discussed the company’s financials as well as its growth strategy and outlook for the remainder of fiscal 2022 as well as 2023The company noted it had exited a period of investment and is now focusing on executionThe period of investment saw the company acquire synergistic brands that, collectively, create a direct-to-consumer house of brands, enabling the company to enter nearly any target market regardless of the legal status of cannabisThe company also invested in the infrastructure necessary for the activation of its cultivation facility in Colombia, enabling…

MondayOct 31, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Moves to Address Adverse Effects of Hypertension with DehydraTECH(TM) – CBD

Lexaria is a drug delivery technology company developing DehydraTECH-CBD as a prospective registered treatment for hypertension and potentially other disease states beyond hypertensionThe company has undertaken multiple de-risking hypertension studies that have not only evidenced that DehydraTECH-CBD is safe and well tolerated, but have also shown that it reduces blood pressure and arterial stiffnessHypertension is a leading contributor to deaths in the United States, damaging organs such as the heart, brain, and kidneys, yet only a tiny proportion of patients have it under control Hypertension, an area of interest and focus for drug delivery technology company Lexaria Bioscience (NASDAQ: LEXX),…

WednesdayOct 26, 2022 10:30 am

Cepton, Inc. (NASDAQ: CPTN) Enables Tier-1 OEMs To Prepare for Safety-Centric Future with Cost-Effective Lidar Integration

Automotive industry faces massive disruption led by adoption of emission reduction mandates, software-centric driving systems, and ADAS/AV technologyEntering execution phase of higher levels of ADAS and AV technology with several OEMs preparing to build fully or near-fully autonomous vehicles ready for public roadsLidar complements camera-based perception technology by “seeing” things in 3D rather than 2DCepton is taking lidar mainstream by engaging with leading global automotive OEMs to cost-effectively deploy lidar at scale The automotive industry has faced massive disruption in the last few years, led primarily by the adoption of emission reduction mandates, software-centric driving systems, and autonomous vehicle (“AV”)…

TuesdayOct 25, 2022 9:45 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Potential Hypertension Medication Poised to Reduce Risk of Blood-Pressure-Induced Dementia, Cognitive Decline

Lexaria Bioscience is a global innovator in drug delivery platforms that has developed the patented DehydraTECH(TM) technology for improved delivery of bioactive compoundsThe company is currently evaluating DehydraTECH-processed CBD as a potential treatment for high blood pressureLong-term studies have shown that high blood pressure can increase the risk of developing dementia in later lifeExperts, however, believe that hypertension medication could slow the pace of the cognitive declineIn addition to helping hypertension patients keep their condition under control, Lexaria’s DehydraTECH-CBD, which has so far been shown to be safe and well tolerated, could potentially help reduce the risk of dementia Blood…

MondayOct 24, 2022 9:45 am

Cepton, Inc. (NASDAQ: CPTN) to Help Accelerate Advancement of Vehicle Autonomy; Collaborates with NVIDIA DRIVE Sim(TM) to Add Its Lidar Models into Simulation Platform for Autonomous Driving

Cepton announced a collaboration with NVIDIA, a cutting-edge platform for large-scale, accurate multi-sensor simulation for autonomous driving; developed sensor ecosystem is essential for AV development and validation in simulationNVIDIA DRIVE Sim(TM) allows users to test Cepton lidars and accelerate and scale deployment; Company expects to accelerate development of lidars for assisted and autonomous driving for global customers through this collaboration At the recent IAA Transportation 2022 conference, Cepton exhibited its Nova lidar integrated into a heavy-duty truck headlamp by ZKW Group GmbH “Lidar is essential to autonomous mobility, but deploying lidar at scale entails extensive testing and validation, sometimes in scenarios…

ThursdayOct 20, 2022 1:30 pm

Commercial Traffic Infrastructure Projects and Supply Chain Tech Innovations by Freight Technologies Inc. (NASDAQ: FRGT) Highlight Economic Value of Cross-border Trade

Houston-headquartered Freight Technologies Inc. is an AI-driven technology developer focused on supporting the commercial trucking industry through efficient and transparent operationsRecent discussion of cross-border traffic infrastructure projects by Mexico’s and the United States’ ambassadors underscores the importance the two nations place on their mutual trade infrastructureFreight Technologies’ Fr8App B2B marketplace helps improve communications between carriers and shippers so they can more efficiently match loads and avoid empty milesThe company is reporting new record quarterly revenue and expects improving market conditions as the nation continues to rebound from COVID’s economic effects When Mexico’s ambassador to the United States Esteban Moctezuma outlined…

ThursdayOct 20, 2022 9:45 am

Cepton, Inc.’s (NASDAQ: CPTN) Lidar Surveillance Solutions Offer Distinct Advantages Over Camera-Only Systems – Protecting Privacy and Eliminating AI Bias

Commonly used surveillance cameras employ AI-powered facial recognition technology that can compromise privacy and lead to biased decisionsLidar may hold the key to privacy-focused solutions by feeding purely behavior-based and biometric-free data into systemsCepton’s lidar-based solutions are developing substantial traction with pilot systems in-place for airport terminal monitoring, highway e-tolling, early-warning intrusion detection, and railway obstacle detectionCepton is currently engaged in discussions with every top-10 global automotive OEM to provide lidar-based perception solutions for automotive applications (e.g., AV and ADAS systems) Facial recognition technology is increasingly being used to monitor public and private spaces, leading to widespread concerns that AI-enabled…

WednesdayOct 19, 2022 11:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Using Novel DehydraTECH(TM) Technology to Address Unmet Antihypertension Drug Market

Research has shown that co-occurring conditions may be linked to high blood pressure, including bone aging and mental illness The antihypertension drug market is anticipated to rise due to the launch of novel pharmaceuticals and diagnostic agents Valued at US $30.2 billion in 2021, the market is expected to grow at a CAGR of 3%, resulting in a value of US $40 billion by 2031 Lexaria’s patented DehydraTECH(TM) technology offers higher bioavailability of active pharmaceutical ingredients due to, in part, bypassing first-pass-liver processing, improving the speed of onset, and brain absorption The American Heart Association (“AMA”) refers to high blood…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000